Analysis: Amrutanjan Health Care Limited

NSE:AMRUTANJAN Pharma - Formulators Market cap: ₹1.5K cr

What does Amrutanjan Health Care Limited do?

  • Amrutanjan Health Care Limited, founded in 1893, is a legacy wellness brand known for pain relief products like Amrutanjan Balm.
  • Evolved from a patent medicine business to a diversified wellness company with categories in pain management, women’s hygiene, rehydration, and congestion.
  • Headquartered in Chennai, India, with a vision to become a global wellness leader by expanding into international markets.
  • Pain Management: Topical balms, sprays, and patches (e.g., Amrutanjan Balm, Maha Strong, Back Pain Roll-On).
  • Women’s Hygiene: Comfy sanitary pads (revenue ~25% of total sales).
  • Rehydration: Electro+ O.R.S (WHO-approved variants) and hydration solutions.
  • Congestion Relief: Cold rubs and inhalers (e.g., Relief Inhaler).

Growth thesis

Amrutanjan Health Care is a 130-year-old Ayurvedic FMCG company selling OTC pain relief (Amrutanjan balm), women’s hygiene (Comfy pads), and health beverages (ElectroPlus). Key growth drivers include Rs 123 crore capex for a dedicated Comfy plant (FY25) to boost EBIT margins by 200 bps to 13-14%, new product launches like GP Paracetamol (FY25) and antifungal spray Stop Pain, and distribution expansion targeting 1 lakh new chemist outlets in 2-3 years. Quick commerce revenue is growing at 200% MoM, while ElectroPlus benefits from global warming-driven rehydration demand. The Rs 1,000 crore revenue target by FY28 hinges on pain category recovery, Comfy’s margin normalization, and successful execution of digitization and SAP integration. Key execution risk: margin compression from pricing pressures in the OTC pain segment.

Why is Amrutanjan Health Care Limited stock rising?

  • Targeting Rs 1000 crore turnover as an aspirational stretch target
  • Pain management category expected to return to low double-digit growth
  • Launching GP Paracetamol (tablets) as a new brand this year
  • Adding at least 1 lakh new chemist pharmacies to distribution in next 2-3 years
  • Capex of Rs 123 crores approved for Comfy manufacturing plant

Research report

companyname: Amrutanjan Health Care Limited ticker: AMRUTANJAN sector: Healthcare / FMCG (Ayurvedic pharmaceuticals, women's hygiene, beverages) Amrutanjan Health Care is one of the oldest FMCG companies in India, incorporated in 1936 but tracing its founding product back to 1893. It manufactures and sells pain relief products (balms, roll-ons, sprays), sanitary napkins, and rehydration drinks. The company operates three manufacturing units, works with 1,656 distributors, and reaches 1.11 milli...

Read the full report →

Catalysts

capex, margin expansion, new product segment

Growth guidance

Rs 1000 crores revenue target by FY28

RS rating: 21 Stage: Stage 4

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Amrutanjan Health Care Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.